These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 1904327)
1. The role of aldose reductase inhibition in diabetic neutrophil phagocytosis and killing. Tebbs SE; Gonzalez AM; Wilson RM Clin Exp Immunol; 1991 Jun; 84(3):482-7. PubMed ID: 1904327 [TBL] [Abstract][Full Text] [Related]
2. Neutrophil phagocytosis and killing in insulin-dependent diabetes. Wilson RM; Reeves WG Clin Exp Immunol; 1986 Feb; 63(2):478-84. PubMed ID: 3084140 [TBL] [Abstract][Full Text] [Related]
3. The influence of aldose reductase on the oxidative burst in diabetic neutrophils. Tebbs SE; Lumbwe CM; Tesfaye S; Gonzalez AM; Wilson RM Diabetes Res Clin Pract; 1992 Feb; 15(2):121-9. PubMed ID: 1314160 [TBL] [Abstract][Full Text] [Related]
4. Nicotinamide effects oxidative burst activity of neutrophils in patients with poorly controlled type 2 diabetes mellitus. Osar Z; Samanci T; Demirel GY; Damci T; Ilkova H Exp Diabesity Res; 2004; 5(2):155-62. PubMed ID: 15203886 [TBL] [Abstract][Full Text] [Related]
5. Impairment of type III group B Streptococcus-stimulated superoxide production and opsonophagocytosis by neutrophils in diabetes. Mazade MA; Edwards MS Mol Genet Metab; 2001 Jul; 73(3):259-67. PubMed ID: 11461193 [TBL] [Abstract][Full Text] [Related]
6. Effects of ponalrestat, an aldose reductase inhibitor, on neutrophil killing of Escherichia coli and autonomic function in patients with diabetes mellitus. Boland OM; Blackwell CC; Clarke BF; Ewing DJ Diabetes; 1993 Feb; 42(2):336-40. PubMed ID: 8425670 [TBL] [Abstract][Full Text] [Related]
7. Effect of aldose reductase inhibitor (Ponalrestat) on erythrocyte Na,K-ATPase activity in non-insulin-dependent diabetic patients with polyneuropathy. Umeda F; Noda K; Hashimoto T; Yamashita T; Nawata H Diabetes Res; 1989 Nov; 12(3):125-9. PubMed ID: 2561396 [TBL] [Abstract][Full Text] [Related]
8. Monitoring of polymorphonuclear leukocyte functions in diabetes mellitus--a comparative study of conventional radiometric function tests and low-light imaging systems. Marhoffer W; Stein M; Schleinkofer L; Federlin K J Biolumin Chemilumin; 1994; 9(3):165-70. PubMed ID: 7942121 [TBL] [Abstract][Full Text] [Related]
9. Short term effect of an aldose reductase inhibitor on urinary albumin excretion rate (UAER) and glomerular filtration rate (GFR) in type 1 diabetic patients with incipient nephropathy. Ranganathan S; Krempf M; Feraille E; Charbonnel B Diabete Metab; 1993; 19(2):257-61. PubMed ID: 8339858 [TBL] [Abstract][Full Text] [Related]
10. Fast anterograde axonal transport in wasted and non-wasted diabetic rats; effects of aldose reductase inhibition. Whiteley SJ; Townsend J; Tomlinson DR; Willars GB Diabetes Res; 1986 Nov; 3(9):447-52. PubMed ID: 2435444 [TBL] [Abstract][Full Text] [Related]
11. Neutrophil sorbitol production impairs oxidative killing in diabetes. Wilson RM; Tomlinson DR; Reeves WG Diabet Med; 1987; 4(1):37-40. PubMed ID: 2951217 [TBL] [Abstract][Full Text] [Related]
12. Berberine inhibits aldose reductase and oxidative stress in rat mesangial cells cultured under high glucose. Liu W; Liu P; Tao S; Deng Y; Li X; Lan T; Zhang X; Guo F; Huang W; Chen F; Huang H; Zhou SF Arch Biochem Biophys; 2008 Jul; 475(2):128-34. PubMed ID: 18471986 [TBL] [Abstract][Full Text] [Related]
13. Activities of aldose reductase, ATPases, and nucleotide concentrations of erythrocytes in patients with type 2 (non-insulin-dependent) diabetes mellitus. Song HP; Han XY; He Y; Kang TB; Wu HW Chin Med J (Engl); 1991 Oct; 104(10):818-24. PubMed ID: 1661222 [TBL] [Abstract][Full Text] [Related]
15. Sorbitol, myo-inositol, and rod outer segment phagocytosis in cultured hRPE cells exposed to glucose. In vitro model of myo-inositol depletion hypothesis of diabetic complications. Del Monte MA; Rabbani R; Diaz TC; Lattimer SA; Nakamura J; Brennan MC; Greene DA Diabetes; 1991 Oct; 40(10):1335-45. PubMed ID: 1936595 [TBL] [Abstract][Full Text] [Related]
16. Modification of the glyoxalase system in streptozotocin-induced diabetic rats. Effect of the aldose reductase inhibitor Statil. Phillips SA; Mirrlees D; Thornalley PJ Biochem Pharmacol; 1993 Sep; 46(5):805-11. PubMed ID: 8373434 [TBL] [Abstract][Full Text] [Related]
17. Kinetic and spectroscopic evidence for active site inhibition of human aldose reductase. Nakano T; Petrash JM Biochemistry; 1996 Aug; 35(34):11196-202. PubMed ID: 8780524 [TBL] [Abstract][Full Text] [Related]
18. The effect of aldose reductase inhibitor Statil (ICI 128436) on the glucose over-utilization in kidney of diabetic rats. Sochor M; Kunjara S; McLean P Biochem Pharmacol; 1988 Sep; 37(17):3349-56. PubMed ID: 2969732 [TBL] [Abstract][Full Text] [Related]